Bezafibrate in the treatment of hyperlipidemia
Lang, P.D.
Boletin de la Asociacion Medica de Puerto Rico 81(2): 59-60
1989
ISSN/ISBN: 0004-4849 PMID: 2712962 Document Number: 700260
Document emailed within 1 workday
Related Documents
Kunesová, M.; Honková, M.; Zeman, M.; Mares, P.; Skorepa, J. 1983: Therapeutic effects of bezafibrate in hyperlipidemia Casopis Lekaru Ceskych 122(20): 628-631Vílchez Joya, R.; Escobar Jiménez, F.; Campos, M.M.; Torres, E.; Orduña, R.; Cabrera, J.; Núñez, J. 1986: Effects of bezafibrate in patients with combined hyperlipidemia Medicina Clinica 86(5): 190-194
Smith, D.H.; Neutel, J.M.; Jankelow, D.; Myburgh, D.P. 1990: Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia South African Medical Journal 77(10): 500-503
Curtis, L.D.; Dickson, A.C.; Ling, K.L.; Betteridge, J. 1988: Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia Bmj 297(6642): 173-175
Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187
Vanhanen, H. 2004: Blocking the absorption of cholesterol in the treatment of hyperlipidemia--old and new ways of treatment Duodecim; Laaketieteellinen Aikakauskirja 120(9): 1105-1110
Haraldsen, M. 1996: Treatment of hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(1): 112
Noseda, G. 1990: Drug treatment of hyperlipidemia Therapeutische Umschau. Revue Therapeutique 47(6): 499-508
Kaffarnik, H. 1982: Is there an age limit in the treatment of hyperlipidemia? Die Medizinische Welt 33(17): 651
Stone, W.L.; Chin, T.K. 2001: Drugs for the treatment of hyperlipidemia Idrugs: the Investigational Drugs Journal 4(7): 788-794
Weintraub, M.; Grosskopf, I.; Rubinstein, A. 1995: Principles of dietary treatment in hyperlipidemia Harefuah 128(9): 556-561
Tonstad, S.; Leren, T.P.; Ose, L. 1997: Diagnosis and treatment of severe hyperlipidemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(29): 4241-4244
Maxwell, M.H.; Heber, D. 1990: Nutritional treatment of hyperlipidemia and obesity Cardiovascular Clinics 20(3): 149-156
Tanaka, K.; Honjo, H. 2001: Clinical feature and treatment of the postmenopausal hyperlipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 766-770
Stratmann, F.W. 1982: What are the possibilities in the treatment of primary hyperlipidemia in diabetes mellitus? Die Medizinische Welt 33(17): 651
Panchenko, V.M.; Ershov, A.A.; Isaev, V.A.; ZImovchenko, G.S.; Chernova, G.I. 2001: Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus Klinicheskaia Meditsina 79(6): 47-49
Drouin, P.; Gay, G.; Pointel, J.P.; Sauvanet, J.P.; Debry, G. 1975: Long-term treatment of hyperlipidemia (apropos of 32 cases observed for 6-36 months) Semaine des Hopitaux. Therapeutique 51(9): 449-455
Boberg, J.; Gustafson, A. 1970: Serum-lipid reducing principles--possibilities for treatment. 2. Classification of hyperlipidemia Lakartidningen 67: Suppl Iv: 40+
Knight, R.J.; Vathsala, A.; Schoenberg, L.; Camel, S.; Weinberg, R.B.; Goldstein, R.A.; Lewis, R.M.; van Buren, C.T.; Kahan, B.D. 1992: Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification Transplantation 53(1): 224-225
Caramelli, B.; de Bernoche, C.Y.; Sartori, A.M.; Sposito, A.C.; Santos, R.D.; Monachini, M.C.; Strabelli, T.; Uip, D. 2001: Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofibrate Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 5(6): 332-338